TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30629601

Group type: EXPERIMENTAL
Intervention: Interval walking training (IWT) with additional support (goal-setting, ecological momentary assessment, and personalized phone-calls) for 12 weeks.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Interval walking training (IWT) without additional support for 12 weeks (control group).
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Experimental group (IWT with support)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (IWT without support)
Number of subjects: 37
Study: 29886354

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 30
Study: 27920497

Group type: EXPERIMENTAL
Intervention: CKD‐828 2.5/40 mg
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: CKD‐828 2.5/80 mg
Number of subjects: 187

Group type: COMPARATOR
Intervention: S‐amlodipine 2.5 mg
Number of subjects: 187
Study: 24656636

Group type: EXPERIMENTAL
Intervention: Antiperspirant containing aluminum chlorohydrate
Number of subjects: 52
Study: 23682544

Group type: EXPERIMENTAL
Intervention: 100% O2 at 1 atm abs (101 kPa)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100% O2 at 1.5 atm abs (152 kPa)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100% O2 at 2 atm abs (203 kPa)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100% O2 at 1-2 atm abs
Number of subjects: 12
Study: 21336439

Group type: EXPERIMENTAL
Intervention: Early feeding (EF) on the first postoperative day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional postoperative dietary regimen (TRAD)
Number of subjects: 29
Study: 19102361

Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 15725174

Group type: EXPERIMENTAL
Intervention: Staff training in mouth care (lecture, video material, clinical demonstrations)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Staff training in mouth care
Number of subjects: 78
Study: 12669122

Group type: EXPERIMENTAL
Intervention: Once daily subcutaneous LMWH (bemiparin) for one week (group B)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Once daily bemiparin in a therapeutic dose for one week followed by a maintenance dose for 12 weeks (group C)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Intravenous unfractionated heparin (group A)
Number of subjects: 378
Study: 10383514

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 219

Group type: COMPARATOR
Intervention: Ranitidine 150 mg
Number of subjects: 219
Study: 8826783

Group type: EXPERIMENTAL
Intervention: Hydrocolloid occlusive dressing technique
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional wet‐to‐dry gauze dressing technique
Number of subjects: 44
Study: 1384566

Group type: EXPERIMENTAL
Intervention: Interactive language intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Delayed treatment (control)
Number of subjects: 32
Study: 3972652

Group type: EXPERIMENTAL
Intervention: Benznidazole (up to 40 mg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: CCNU (130 mg/m2)
Number of subjects: 34
Study: 30858208

Group type: EXPERIMENTAL
Intervention: Omadacycline 200 mg i.v. on day 1, then 300 mg orally q24h
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Omadacycline 300 mg orally q12h on day 1, then 300 mg orally q24h
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Omadacycline 450 mg orally q12h on day 1, then 450 mg orally q24h
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Omadacycline (all groups)
Number of subjects: 31
Study: 29126207

Group type: EXPERIMENTAL
Intervention: 30% GWL
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: 50% GWL
Number of subjects: 475

Group type: COMPARATOR
Intervention: No GWL (control)
Number of subjects: 475
Study: 26540136

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (100,000 IU load plus 4,000 IU/d) for 28 weeks
Number of subjects: 408

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Vitamin D sufficiency responders
Number of subjects: 408
Study: 24556755

Group type: EXPERIMENTAL
Intervention: Intervention group (n=24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n=26)
Number of subjects: 50
Study: 22340605

Group type: EXPERIMENTAL
Intervention: Optimized Prolate Ablation (OPA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Optical Path Difference Custom Aspheric Treatment (OPDCAT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Prolate Ablation (OPA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Aspheric Ablation (OPDCAT)
Number of subjects: 39
Study: 20036036

Group type: EXPERIMENTAL
Intervention: Apex-Anterior (A-A) electrode position
Number of subjects: 91

Group type: COMPARATOR
Intervention: Left Anteroposterior (A-P) electrode position
Number of subjects: 91
Study: 17572410

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily for 6 months
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 75
Study: 15969897

Group type: EXPERIMENTAL
Intervention: Montelukast 4‐mg oral granules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14616102

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 1079

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1079
Study: 10572288

Group type: EXPERIMENTAL
Intervention: Wisconsin Card Sorting Test for malingering detection in undergraduates
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Wisconsin Card Sorting Test for malingering detection in brain injured patients
Number of subjects: 105
Study: 8572359

Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted 8 cm
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted 2 cm
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted > 2 cm
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted 2 or 4 cm
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Epidural catheters resulting in unilateral sensory analgesia
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Epidural catheters resulting in intravenous cannulation
Number of subjects: 800
Study: 8383088

Group type: EXPERIMENTAL
Intervention: Recombinant interferon-alpha 2a (50 x 10(6) IU/m2) intramuscularly three times a week (n = 35)
Number of subjects: 71

Group type: COMPARATOR
Intervention: No antitumor therapy (n = 36)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Recombinant interferon-alpha 2a
Number of subjects: 71
Study: 2828458

Group type: EXPERIMENTAL
Intervention: Melatonin (100 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Evening protocol (20:00 h)
Number of subjects: 6
Study: 29489046

Group type: EXPERIMENTAL
Intervention: Prazosin (alpha-adrenergic agonist)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Covert hostility
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: PTSD symptom severity
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Depression symptoms
Number of subjects: 93
Study: 27439724

Group type: EXPERIMENTAL
Intervention: Oral health promotion intervention (INT) delivered by trained Navajo lay health workers, including 5 interactions for children, 4 for parents, and 4 fluoride varnish applications over 3 years.
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Usual care (UC) control group, no specific intervention details provided.
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: Oral health promotion intervention (INT)
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: Oral health promotion intervention (INT) among adherent children
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Usual care (UC) among non-adherent children
Number of subjects: 1016
Study: 26336931

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg)
Number of subjects: 62
Study: 23506974

Group type: EXPERIMENTAL
Intervention: Choice (selecting between a low-carbohydrate, calorie-unrestricted diet (LCD) or a low-fat, reduced-calorie diet (LFD))
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control (randomly assigned to follow either a low-carbohydrate, calorie-unrestricted diet (LCD) or a low-fat, reduced-calorie diet (LFD))
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Choice (adherence to diet by food frequency questionnaire)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control (adherence to diet by food frequency questionnaire)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Choice (obesity-specific health-related quality of life)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control (obesity-specific health-related quality of life)
Number of subjects: 216
Study: 21674393

Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy using MIME (high-dose, 30 hours)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy using MIME (low-dose, 15 hours)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (conventional therapy, up to 15 hours)
Number of subjects: 54
Study: 18680490

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) 110 microg once daily
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) 55 microg once daily
Number of subjects: 554

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 554
Study: 16919390

Group type: EXPERIMENTAL
Intervention: Glutamate 100mM
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glutamate (various concentrations)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isotonic saline 0.9%
Number of subjects: 30
Study: 15650064

Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Two-stage etch and prime
Number of subjects: 51
Study: 11135504

Group type: EXPERIMENTAL
Intervention: Alternative Program (contacts by local outreach workers, cognitive-behavioral relapse-prevention group counseling, individual counseling for needs assessment and referral)
Number of subjects: 0
Study: 10433045

Group type: EXPERIMENTAL
Intervention: Y-axis inverted imaging condition (experienced surgeons)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal imaging condition (experienced surgeons)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Y-axis inverted imaging condition (novice participants)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal imaging condition (novice participants)
Number of subjects: 32
Study: 7924319

Group type: EXPERIMENTAL
Intervention: TCu 380A IUD
Number of subjects: 0
Study: 2554244

Group type: EXPERIMENTAL
Intervention: Oral rhesus rotavirus vaccine (RRV) with oral poliovirus vaccine (OPV)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo with oral poliovirus vaccine (OPV)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Oral rhesus rotavirus vaccine (RRV) 2 weeks after OPV
Number of subjects: 102
Study: 239517

Group type: EXPERIMENTAL
Intervention: HC20‐511
Number of subjects: 42

Group type: COMPARATOR
Intervention: Dimetinden (Fenistil retard)
Number of subjects: 42
Study: 29386308

Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 27
Study: 28878181

Group type: EXPERIMENTAL
Intervention: DHA (200 mg/day) and ARA (200 mg/day) supplement
Number of subjects: 133

Group type: COMPARATOR
Intervention: Corn oil supplement (control)
Number of subjects: 133
Study: 25043631

Group type: EXPERIMENTAL
Intervention: Making It Work program (5 online group sessions, 5 web-based e-learning modules, consultations with an occupational therapist and vocational rehabilitation counselor)
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Making It Work program
Number of subjects: 526
Study: 23302714

Group type: EXPERIMENTAL
Intervention: Intensive glucose control (hemoglobin A1c target 6.5% or less)
Number of subjects: 11140
Study: 19773666

Group type: EXPERIMENTAL
Intervention: MARS treatment
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 149
Study: 18818679

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: C-reactive protein measurements
Number of subjects: 1255
Study: 15673859

Group type: COMPARATOR
Intervention: Preoperative acustimulation (active device for 30 min before surgery, sham device for 72 h after surgery)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Postoperative acustimulation (sham device for 30 min before surgery, active device for 72 h after surgery)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Perioperative acustimulation (active device for 30 min before and 72 h after surgery)
Number of subjects: 105
Study: 14516031

Group type: EXPERIMENTAL
Intervention: Weight-bearing full-extension radiographs
Number of subjects: 22

Group type: COMPARATOR
Intervention: Weight-bearing 30 degrees flexion radiographs
Number of subjects: 22
Study: 10555605

Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 0
Study: 2081952

Group type: EXPERIMENTAL
Intervention: High-temperature injectable thermoplasticized gutta-percha without sealer
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Low-temperature injectable thermoplasticized gutta-percha with sealer
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Low-temperature injectable thermoplasticized gutta-percha without sealer
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Amalgam with varnish
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Amalgam without varnish
Number of subjects: 105
Study: 523503

Group type: EXPERIMENTAL
Intervention: Furosemide (oral)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Furosemide (intravenous)
Number of subjects: 7
Study: 30556339

Group type: EXPERIMENTAL
Intervention: Hypertension (HBP)
Number of subjects: 568

Group type: COMPARATOR
Intervention: No Hypertension (NBP)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Baseline systolic blood pressure increase
Number of subjects: 568
Study: 27734214

Group type: EXPERIMENTAL
Intervention: Baseline log10GDF‐15
Number of subjects: 147

Group type: COMPARATOR
Intervention: Changes in vascular function
Number of subjects: 147
Study: 26268221

Group type: EXPERIMENTAL
Intervention: Training intervention to improve user and carer involvement in care planning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no training and care planning as usual)
Number of subjects: 0
Study: 24960147

Group type: EXPERIMENTAL
Intervention: etoricoxib 120 mg qd
Number of subjects: 139

Group type: COMPARATOR
Intervention: ibuprofen 600 mg qid
Number of subjects: 139
Study: 21544882

Group type: EXPERIMENTAL
Intervention: Salvia miltiorrhiza hydrophilic extract (SMHE) plus hypoglycemic therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo plus hypoglycemic therapy
Number of subjects: 62
Study: 19687335

Group type: EXPERIMENTAL
Intervention: Vinflunine + Best Supportive Care (BSC)
Number of subjects: 370
Study: 17601439

Group type: EXPERIMENTAL
Intervention: Misted administration of tropicamide 1.0% (6 microl)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional drop administration of tropicamide 1.0% (30 microl)
Number of subjects: 100
Study: 15177812

Group type: EXPERIMENTAL
Intervention: Treatment-refractory patients with schizophrenia
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study: 12408210

Group type: EXPERIMENTAL
Intervention: Behavioral Action Model (BAM)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Precaution Adoption Model (PAM)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Nicotine patch (for smokers ready to quit)
Number of subjects: 288
Study: 9583345

Group type: EXPERIMENTAL
Intervention: Brief treatment of depression (16-week duration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapist ratings, independent clinical evaluator ratings, and patient ratings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Independent assessments during treatment
Number of subjects: 0
Study: 7661573

Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron capsule
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 2589659

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CYS) given 4 to 7 hours preoperatively
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CYS) given less than 4 hours preoperatively
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CYS) given greater than 7 hours preoperatively
Number of subjects: 30
Study: 7002354

Group type: EXPERIMENTAL
Intervention: Combination of Persantine and aspirin
Number of subjects: 2026

Group type: EXPERIMENTAL
Intervention: Aspirin alone
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2026
Study: 31515616

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 124

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 124
Study: 28063795

Group type: EXPERIMENTAL
Intervention: Sputum Xpert‐MTB/RIF and Determine TB LAM urine test (novel diagnostic group)
Number of subjects: 875

Group type: COMPARATOR
Intervention: Laboratory-based sputum smear microscopy (routine diagnostic group)
Number of subjects: 875
Study: 26187377

Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 248
Study: 24358799

Group type: EXPERIMENTAL
Intervention: Adenoidal hypertrophy group (30 children)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (28 children)
Number of subjects: 58
Study: 21979845

Group type: EXPERIMENTAL
Intervention: Provase® (nonprescription moisturizer with protease enzymes)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control moisturizer
Number of subjects: 23
Study: 19995094

Group type: EXPERIMENTAL
Intervention: Prulifloxacin 600 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 19088777

Group type: EXPERIMENTAL
Intervention: Aerobic interval training (4 weeks, 4 bouts of running for 4 min at 90%-95% of maximal heart rate, with 3 min of active recovery)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 26
Study: 15947531

Group type: EXPERIMENTAL
Intervention: Orlistat and diet counseling
Number of subjects: 21

Group type: COMPARATOR
Intervention: Diet counseling alone
Number of subjects: 21
Study: 12503909

Group type: EXPERIMENTAL
Intervention: Length of alcohol abstinence at time of enrollment
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Longest previous period of smoking abstinence
Number of subjects: 85
Study: 9932938

Group type: EXPERIMENTAL
Intervention: APOE-epsilon4 allele
Number of subjects: 69
Study: 8526228

Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Books (control group)
Number of subjects: 0
Study: 2389782

Group type: EXPERIMENTAL
Intervention: Vivid interventions (educational meetings)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nonvivid interventions (educational meetings)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 7014694

Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine cream (15 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiologic saline (14 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Povidone-iodine solution (11 patients)
Number of subjects: 40
Study: 30935737

Group type: COMPARATOR
Intervention: Non-invasive ventilation
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure
Number of subjects: 215
Study: 27029919

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (HMUFA) diet
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with long-chain n-3 polyunsaturated fatty acids (LFHCC n-3)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet (LFHCC)
Number of subjects: 39
Study: 25822100

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, high-fat diet (LC/HFD)
Number of subjects: 29
Study: 23594839

Group type: EXPERIMENTAL
Intervention: Whole meal bread (WMB) meal (2267 kJ)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Whole meal bread (WMB) meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rice pudding (RP) meal
Number of subjects: 12
Study: 21445638

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Zofenopril 30 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 19703285

Group type: EXPERIMENTAL
Intervention: RTube
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ECoScreen
Number of subjects: 40
Study: 18063167

Group type: EXPERIMENTAL
Intervention: Arthroscopic osteoplasty
Number of subjects: 8

Group type: COMPARATOR
Intervention: Open osteoplasty
Number of subjects: 8
Study: 14760306

Group type: EXPERIMENTAL
Intervention: Intubating Laryngeal Mask Airway (I‐LMA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 15
Study: 11695797

Group type: EXPERIMENTAL
Intervention: Right side thoracoscopic sympathectomy (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Left side thoracoscopic sympathectomy (group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (A and B) during phase II after CO2 insufflation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of CO and CI between groups A and B
Number of subjects: 20
Study: 9394089

Group type: EXPERIMENTAL
Intervention: 24 hours of sleep deprivation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Approximately 8 hours of sleep
Number of subjects: 44
Study: 8180764

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compressors (IPC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent electric calf stimulators (IECS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insufflation to 12 mm Hg
Number of subjects: 0